What are the differences in diagnosis, treatment, and management of Subarachnoid Hemorrhage (SAH) in adults, caput succedaneum, and cephalohematoma in newborns?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Distinguishing SAH, Caput Succedaneum, and Cephalohematoma

These are three completely different conditions affecting different age groups and anatomical locations: SAH is a life-threatening intracranial hemorrhage in adults requiring emergency neurosurgical evaluation, while caput succedaneum and cephalohematoma are benign birth-related scalp injuries in newborns that resolve spontaneously.

Subarachnoid Hemorrhage (SAH) - Adult Emergency

Population and Presentation

  • Adults presenting with sudden-onset severe headache described as "the worst headache of my life" (80% of cases), reaching maximal intensity immediately (thunderclap pattern) 1
  • Associated with nausea/vomiting (77%), loss of consciousness (53%), and nuchal rigidity (35%) 1
  • Mortality is 45% at 30 days, with 12% dying before reaching medical attention 2

Anatomical Location

  • Bleeding occurs in the subarachnoid space between the arachnoid mater and pia mater, surrounding the brain 1
  • Most commonly caused by ruptured intracranial aneurysm (80% of cases) 2

Diagnostic Approach

  • Non-contrast head CT is the cornerstone: 98-100% sensitive within first 12 hours, declining to 93% at 24 hours 1
  • If CT negative and high clinical suspicion: perform lumbar puncture looking for xanthochromia and elevated red blood cells 1
  • Digital subtraction angiography to identify aneurysm source 2

Management

  • Immediate neurosurgical consultation - this is a medical emergency 1
  • Maintain systolic blood pressure <160 mmHg to prevent rebleeding 2
  • Nimodipine 60 mg every 4 hours for 21 days to improve neurological outcomes 2
  • Early aneurysm repair (endovascular or surgical) to prevent rebleeding, which has 70% case fatality 2

Caput Succedaneum - Benign Newborn Scalp Edema

Population and Presentation

  • Newborns immediately after delivery, particularly following vacuum-assisted or prolonged vaginal delivery 3
  • Presents as soft, pitting edema of the scalp visible at birth 3

Anatomical Location

  • Superficial to the periosteum in the subcutaneous tissue layer 3
  • Crosses suture lines freely - this is the key distinguishing feature 3
  • Located above the galea aponeurotica

Clinical Course

  • Benign and self-resolving within 24-48 hours without intervention 3
  • No risk of significant blood loss or complications
  • No treatment required

Cephalohematoma - Subperiosteal Blood Collection

Population and Presentation

  • Newborns, typically becoming apparent hours to days after delivery (not immediately visible like caput) 3
  • More common with vacuum or forceps-assisted delivery 4
  • Presents as firm, non-pitting swelling that may enlarge over first 24-48 hours 3

Anatomical Location

  • Subperiosteal hemorrhage - blood collection between skull bone and periosteum 3
  • Does NOT cross suture lines because periosteum is tightly adherent at sutures - this is the critical distinguishing feature 3
  • Most commonly affects parietal bones

Clinical Course and Complications

  • Resolves spontaneously over weeks to months (typically 2-3 months) 3
  • May be associated with hyperbilirubinemia (40% of cases) as blood resorbs 4
  • Can coexist with more serious intracranial injuries: subdural hemorrhage (50%), subarachnoid hemorrhage (15%), or skull fracture (30%) 4
  • Monitor for severe metabolic acidosis (pH <7.0), which is the only prognostic factor associated with mortality 4

Management

  • No intervention required for isolated cephalohematoma 4
  • Monitor hemoglobin if large - 60% required transfusion in one series when associated with subgaleal hemorrhage 4
  • Phototherapy if hyperbilirubinemia develops (mean total bilirubin 13.1 mg/dL) 4
  • Never aspirate - risk of infection and reaccumulation

Critical Distinguishing Features Summary

Feature SAH Caput Succedaneum Cephalohematoma
Age Adults Newborns Newborns
Location Intracranial (subarachnoid space) Scalp (subcutaneous) Subperiosteal
Crosses sutures N/A YES NO
Timing Sudden onset Present at birth Hours to days after birth
Texture N/A Soft, pitting Firm, non-pitting
Mortality 45% 0% <1% (only if severe acidosis)
Treatment Emergency neurosurgery None Observation only

Common Pitfall

Caput succedaneum and cephalohematoma can coexist - if swelling crosses suture lines, do not assume it is only caput succedaneum, as you may miss an underlying cephalohematoma 3. MRI can distinguish if clinically important 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Subarachnoid Hemorrhage Management and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the causes and symptoms of a subarachnoid hemorrhage (SAH)?
What is the treatment for a subarachnoid hemorrhage that is not visible on computed tomography (CT) scan?
What is the characteristic appearance of subarachnoid hemorrhage on a plain Computed Tomography (CT) scan?
What is the presentation and treatment for subarachnoid hemorrhage?
What is the best practice for neonatal care following assisted vaginal birth, is it observation in the Neonatal Intensive Care Unit (NICU) for 4 hours post-delivery, cranial ultrasound examination, deferral of discharge for 48 hours post-delivery, or careful monitoring for signs of sub-galeal hemorrhage?
What is the most likely cause of elevated liver enzymes (alanine transaminase (ALT) greater than aspartate transaminase (AST)) and hyperferritinemia in a young male alcoholic and smoker with normal alkaline phosphatase (ALP) levels?
What are the appropriate management and treatment options for a patient experiencing vertigo?
What does a drop in E1G (Estrogen 1 Glucuronide) to 110 followed by a rise to 128.4, with sustained PdG (Progesterone glucuronide) levels of 20, indicate at 11 and 12 days past the initial LH (Luteinizing Hormone) surge in a patient attempting to conceive?
Are GLP-1 (Glucagon-Like Peptide-1) analogues, such as liraglutide (Victoza) or semaglutide (Ozempic), safe for patients with hyperthyroidism?
A patient with RUQ pain, jaundice, hyperbilirubinemia, leukocytosis, and a dilated common bile duct with multiple gallstones, what is the most likely diagnosis?
What are the management and treatment options for a neonate with cephalohematoma or caput succedaneum?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.